In the last three months, 15 analysts have published ratings on FMC FMC, offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 4 | 8 | 1 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 4 | 1 | 0 |
| 2M Ago | 0 | 1 | 3 | 0 | 0 |
| 3M Ago | 1 | 1 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $54.33, a high estimate of $69.00, and a low estimate of $38.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 19.0%.
Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light on the perception of FMC by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Harrison | Seaport Global | Lowers | Buy | $55.00 | $72.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $51.00 | $55.00 |
| Benjamin Theurer | Barclays | Lowers | Overweight | $48.00 | $65.00 |
| Joshua Spector | UBS | Lowers | Neutral | $38.00 | $66.00 |
| Steve Byrne | B of A Securities | Lowers | Underperform | $48.00 | $61.00 |
| Joel Jackson | BMO Capital | Lowers | Market Perform | $50.00 | $62.00 |
| Vincent Andrews | Morgan Stanley | Lowers | Equal-Weight | $46.00 | $70.00 |
| Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $47.00 | $78.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $61.00 | $55.00 |
| Benjamin Theurer | Barclays | Maintains | Overweight | $65.00 | $65.00 |
| Steve Byrne | B of A Securities | Lowers | Neutral | $61.00 | $63.00 |
| Christopher Parkinson | Mizuho | Lowers | Neutral | $55.00 | $70.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $69.00 | $79.00 |
| Joshua Spector | UBS | Lowers | Buy | $66.00 | $75.00 |
| Patrick Cunningham | Citigroup | Lowers | Neutral | $55.00 | $70.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
For valuable insights into FMC's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on FMC analyst ratings.
Get to Know FMC Better
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Breaking Down FMC's Financial Performance
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining FMC's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.82% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -0.37%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): FMC's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.14%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.78, caution is advised due to increased financial risk.
What Are Analyst Ratings?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
